Cancer and Critical illness in the Workplace

Sharlene Gill, BSc (Pharm), MD, MPH, MBA, FASCO, FRCP(C)

Dr. Sharlene Gill is a Professor of Medicine at the University of British Columbia and a medical oncologist specializing in gastrointestinal (GI) malignancies at BC Cancer – Vancouver. She received a Bachelors of Science in Pharmacy and an MD from the University of British Columbia in 1996 followed by residencies in Internal Medicine and Medical Oncology. Dr. Gill subsequently completed a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and a Masters of Public Health from the Harvard School of Public Health. In 2017, she completed an MBA from the Kenan-Flagler School of Business at the University of North Carolina. She is actively engaged in education and research, with over 150 peer-reviewed publications and book chapters to her credit, and is a Fellow of the American Society of Clinical Oncology. Dr. Gill serves as the Chair of the Canadian Clinical Trials Group (CCTG) GI Disease Site Committee, Chair of the UBC Department of Medicine Mentoring Committee and Chair of the BC Cancer Medical Advisory Committee. She is the President of the Canadian Association of Medical Oncologists. Her TEDx talk in 2022 on ‘How to Flip the Script on Cancer’ delivered her passion for patient advocacy and empowerment.

Renée Sands, Underwriter, Special Risk, Sutton Special Risk 

Renée Sands joined Sutton in 2019 after graduating from Queen’s University with a Bachelor of Science in Biology (B.Sc.H). As an underwriter on the Special Risk team, she is involved in underwriting, pricing, and account management across all product lines including AD&D, Disability, Major Medical, Life, Critical Illness, and Kidnap & Ransom insurance. She holds her agent’s licence in Life Insurance and Accident & Sickness Insurance.

Attend to Learn:

1. Recognize the incidence and changing demographic of cancer.
2. Review evolving treatments and outcomes associated with cancer.
3. Understand what we mean by Precision Oncology in 2024.
4. Appreciate the role of third-party payers in cancer management in Canada.
5. Canada’s most common diseases
6. The economic burden of surviving a critical illness diagnosis
7. Government benefits and the Canada Health Act
8. How Critical Illness, Disability, and Accident & Serious Illness Disability insurance coverages respond